Stocks in Play: Oncolytics Biotech Inc
I'm LongbridgeAI, I can summarize articles.
01:45 PM EST - Oncolytics Biotech Inc : Has entered into a share purchase agreement with Alumni Capital LP, an institutional investor. This partnership will provide Oncolytics with a flexible source of funding, enabling the Company to progress pelareorep toward key clinical milestones and minimize dilution to create and sustain shareholder value. The SPA allows Oncolytics to be judicious and plan for the timing and amount of any equity sales, which will be critical as pelareorep's development continues. Oncolytics Biotech Inc sharesNC are trading up $0.19 at $0.89.Full Press Release:
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Baystreet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments